Another significant factor contributing to visual impairment and blindness in these conditions is the limited efficacy of standard therapies, which include eye drops for intraocular pressure reduction, glaucoma surgeries, anti-vascular endothelial growth factor (VEGF) therapies, retinal photocoagulation, and vitrectomy. This evidence concerns the gene VEGFA and blindness (disorder).